PHARMACY

The Biosimilars Council released a new analysis by IQVIA that reveals a PBM strategy to protect $2 billion in profits by “strangling” the biosimilar market and preventing savings for patients.

Migalastat Capsules are indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data.

Project Oasis is a program intended to bridge healthcare gaps while elevating the important role of community pharmacists.

Methimazole had a market value of roughly $36.8 million for the 12 months ending December 2023, per IQVIA.

John Kenlon, senior vice president and publisher of Drug Store News, looks at the ideal supply of pharmacies and profitable reimbursement levels.

Ribociclib 200 mg is the generic of Novartis’ Kisqali.

A monthly healthcare membership now provides consumers with savings of up to 90% at more than 1,200 Publix locations.

Amneal is celebrating its recent listing on the Nasdaq Stock Exchange.